-transparent.png){kind=logo}
The synthesis and in vitro anti-HIV activity of tBuSATE phosphoramidate derivatives of AZT incorporating several methyl-esterified alpha-amino acids are reported. The biological evaluation strongly supports the hypothesis that such compounds exert their anti-HIV effects via intracellular delivery of the corresponding 5'-mononucleotide.
Related Publications
D Egron, and
C Périgaud, and
G Gosselin, and
A M Aubertin, and
J L Imbach
July 1999,
Antiviral research,
D Egron, and
C Périgaud, and
G Gosselin, and
A M Aubertin, and
J L Imbach
September 1995,
Journal of medicinal chemistry,
D Egron, and
C Périgaud, and
G Gosselin, and
A M Aubertin, and
J L Imbach
March 2012,
Medicinal chemistry (Shariqah (United Arab Emirates)),
D Egron, and
C Périgaud, and
G Gosselin, and
A M Aubertin, and
J L Imbach
January 1991,
Antiviral research,
D Egron, and
C Périgaud, and
G Gosselin, and
A M Aubertin, and
J L Imbach
October 1999,
Nucleosides & nucleotides,
D Egron, and
C Périgaud, and
G Gosselin, and
A M Aubertin, and
J L Imbach
May 2003,
Antiviral chemistry & chemotherapy,
D Egron, and
C Périgaud, and
G Gosselin, and
A M Aubertin, and
J L Imbach
January 1999,
Antiviral research,
D Egron, and
C Périgaud, and
G Gosselin, and
A M Aubertin, and
J L Imbach
February 2003,
Journal of medicinal chemistry,
D Egron, and
C Périgaud, and
G Gosselin, and
A M Aubertin, and
J L Imbach
January 1998,
Bioorganic & medicinal chemistry letters,
D Egron, and
C Périgaud, and
G Gosselin, and
A M Aubertin, and
J L Imbach
July 2007,
Bioorganic & medicinal chemistry letters,
